Blueshift Asset Management’s GSK GSK Stock Holding History

Blueshift Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-8,599	Closed	-$331K	–	407
2024 Q2	$331K	Buy	+8,599	New	+$362K	0.11%	227
2023 Q3	–	Sell	-5,719	Closed	-$204K	–	339
2023 Q2	$204K	Buy	+5,719	New	+$205K	0.08%	303
2022 Q4	–	Sell	-23,640	Closed	-$696K	–	461
2022 Q3	$696K	Buy	+23,640	New	+$896K	0.15%	197
2022 Q2	–	Sell	-3,991	Closed	-$217K	–	805
2022 Q1	$217K	Buy	+3,991	New	+$217K	0.02%	714
2021 Q2	–	Sell	-21,130	Closed	-$943K	–	1010
2021 Q1	$943K	Buy	21,130 +3,574	+20%	+$162K	0.1%	289
2020 Q4	$808K	Buy	17,556 +8,610	+96%	+$395K	0.1%	310
2020 Q3	$421K	Buy	+8,946	New	+$448K	0.06%	381
2019 Q4	–	Sell	-15,997	Closed	-$853K	–	881
2019 Q3	$853K	Buy	15,997 +2,537	+19%	+$131K	0.13%	225
2019 Q2	$673K	Buy	13,460 +2,697	+25%	+$135K	0.09%	334
2019 Q1	$562K	Sell	10,763 -566	-5%	-$28.3K	0.08%	368
2018 Q4	$541K	Buy	+11,329	New	+$558K	0.1%	329

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Blueshift Asset Management's GSK Position: Q3 2024 in Review

Blueshift Asset Management sold out of GSK (GSK) in Q3 2024, closing a stake of 8,599 shares — an estimated $331K sold.

Blueshift Asset Management first reported a position in GSK in Q4 2018 and held it in 11 quarters. The position peaked at $943K in Q1 2021. 899 funds tracked by Wall St. Rank hold GSK as of Q3 2024.

Blueshift Asset Management reported no remaining GSK position as of Q3 2024 after selling out during the quarter.
Blueshift Asset Management sold 8,599 GSK shares in Q3 2024, an estimated $331K.
Blueshift Asset Management first reported a position in GSK in Q4 2018 and held it in 11 quarters.
Blueshift Asset Management's GSK position peaked at $943K in Q1 2021.
899 funds tracked by Wall St. Rank held GSK as of Q3 2024.

Based on Blueshift Asset Management's 13F filing for Q3 2024, filed 13 Nov 2024.